<code id='F070E68744'></code><style id='F070E68744'></style>

<acronym id='F070E68744'></acronym>

<center id='F070E68744'><center id='F070E68744'><tfoot id='F070E68744'></tfoot></center><abbr id='F070E68744'><dir id='F070E68744'><tfoot id='F070E68744'></tfoot><noframes id='F070E68744'>

<optgroup id='F070E68744'><strike id='F070E68744'><sup id='F070E68744'></sup></strike><code id='F070E68744'></code></optgroup>

<b id='F070E68744'><label id='F070E68744'><select id='F070E68744'><dt id='F070E68744'><span id='F070E68744'></span></dt></select></label></b><u id='F070E68744'></u>

~~<i id='F070E68744'><strike id='F070E68744'><tt id='F070E68744'><pre id='F070E68744'></pre></tt></strike></i>~~

Home» focus» hotspot

hotspot

hotspot

author：knowledge 2025-09-13 21:56:46 Page View：317

Alexis Borisy — Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence
Next article： Supreme Court strikes down use of affirmative action

explore

Alkermes shareholders re

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

Being 'nonadherent' patient made me a more empathetic doctor

Being 'nonadherent' patient made me a more empathetic doctor

AdobeWhenIwas13yearsold,Ihadtotake11pillseveryday.Ihadnon-Hodgkin’slymphoma,andthesepillsworkedeithe

George Santos makes 1st court appearance after pleading not guilty to 13 counts

George Santos makes 1st court appearance after pleading not guilty to 13 counts

1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

Setback for rare diseases as Taysha Gene Therapies pulls back

AdobeIn2020,asbiotechstockssurgedamidthepandemic,astartupcalledTayshaGeneTherapiesraisedover$300mill

read more